Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 oct. 2019 07h47 HE | Source: Rich Pharmaceuticals

Rich Pharmaceuticals Reaches Agreement with Geopulse Exploration, Inc. (Cannco Brands)

LOS ANGELES, CA, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) has agreed to be partially acquired by Geopulse Exploration, Inc. (OTC PINK: GPLS),...
10 avr. 2018 07h00 HE | Source: Rich Pharmaceuticals

Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients

BEVERLY HILLS, CA , April 10, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
14 mars 2018 09h45 HE | Source: Rich Pharmaceuticals

Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma

BEVERLY HILLS, CA , March 14, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
06 mars 2018 09h45 HE | Source: Rich Pharmaceuticals

Rich Pharmaceuticals' Study Drug RP-323 (TPA) Elevates White Blood Cells (WBCs) Which Play a Vital Role Fighting Infections, and in Immunotherapy

BEVERLY HILLS, CA, March 06, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), is a Biopharmaceutical Company focused on developing and commercializing innovative therapies in...
05 déc. 2017 12h35 HE | Source: Rich Pharmaceuticals

UPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials

BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...
05 déc. 2017 10h35 HE | Source: Rich Pharmaceuticals

Rich Pharmaceuticals Retains Experienced Contact Research Organization to Assist with Clinical Trials

BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...